Abstract
The effect of glucagon at various infusion rates on plasma levels of somatostatin-like immunoreactivity (SLI) was examined in conscious normal and chronic alloxan diabetic dogs. In normal dogs glucagon infused at 6, 36, and 120 ng/kg per min did not affect the peripheral venous plasma SLI levels. In diabetic dogs, however, peripheral venous plasma SLI levels in inferior vena cava rose significantly from a mean base-line value of 181±9 pg/ml to a peak value of 279±38 pg/ml during the infusion of 120 μg/kg per min of glucagon, which raised plasma immunoreactive glucagon to >5,000 pg/ml. This glucagon-mediated increase was completely abolished by coinfusion of 7 mU/kg per min of insulin, a rate that maintained the ratio of insulin to glucagon at approximately the baseline value.
In anesthetized normal dogs the concentration of SLI in the venous effluent of the pancreas, the gastric fundus and the antrum increased significantly with each infusion rate of glucagon using including the lowest rate of 4 ng/kg per min, which raised the plasma level of glucagon to 395±19 pg/ml. This stimulatory effect on SLI secretion was completely abolished by insulin coinfusion at a rate designed to maintain the insulin to glucagon ratio at approximately the baseline value, but the effect of a high 90-ng/kg per min infusion on pancreatic and gastric SLI release was not suppressed by coinfusion of 10 mU/kg per min insulin.
These results suggest that glucagon stimulates splanchnic D cells unless insulin secretion is proportionally stimulated and suggests that the splanchnic D cell is a common target upon which the two hormones exert opposing actions. The loss of insulin inhibition of glucagon-mediated somatostatin secretion may account for the hypersomatostatinemia of severe diabetes.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arimura A., Sato H., Coy D. H., Schally A. V. Radioimmunoassay for GH-release inhibiting hormone. Proc Soc Exp Biol Med. 1975 Mar;148(3):784–789. doi: 10.3181/00379727-148-38631. [DOI] [PubMed] [Google Scholar]
- Chiba T., Seino Y., Goto Y., Kadowaki S., Taminato T., Abe H., Kato Y., Matsukura S., Nozawa M., Imura H. Somatostatin release from isolated perfused rat stomach. Biochem Biophys Res Commun. 1978 May 30;82(2):731–737. doi: 10.1016/0006-291x(78)90936-1. [DOI] [PubMed] [Google Scholar]
- Gerber P. P., Trimble E. R., Wollheim C. B., Renold A. E. Effect of insulin on glucose- and arginine-stimulated somatostatin secretion from the isolated perfused rat pancreas. Endocrinology. 1981 Jul;109(1):279–283. doi: 10.1210/endo-109-1-279. [DOI] [PubMed] [Google Scholar]
- Harris V., Conlon J. M., Srikant C. B., McCorkle K., Schusdziarra V., Ipp E., Unger R. H. Measurements of somatostatin-like immunoreactivity in plasma. Clin Chim Acta. 1978 Jul 15;87(2):275–283. doi: 10.1016/0009-8981(78)90348-0. [DOI] [PubMed] [Google Scholar]
- Kawai K., Ipp E., Orci L., Perrelet A., Unger R. H. Circulating somatostatin acts on the islets of Langerhans by way of a somatostatin-poor compartment. Science. 1982 Oct 29;218(4571):477–478. doi: 10.1126/science.6126931. [DOI] [PubMed] [Google Scholar]
- Kronheim S., Berelowitz M., Pimstone B. L. A radioimmunoassay for growth hormone release-inhibiting hormone: method and quantitative tissue distribution. Clin Endocrinol (Oxf) 1976 Nov;5(6):619–630. doi: 10.1111/j.1365-2265.1976.tb03865.x. [DOI] [PubMed] [Google Scholar]
- Patton G. S., Ipp E., Dobbs R. E., Orci L., Vale W., Unger R. H. Pancreatic immunoreactive somatostatin release. Proc Natl Acad Sci U S A. 1977 May;74(5):2140–2143. doi: 10.1073/pnas.74.5.2140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rouiller D., Schusdziarra V., Unger R. H. Insulin inhibits somatostatin-like immunoreactivity release stimulated by intragastric HCl. Diabetes. 1981 Sep;30(9):735–738. doi: 10.2337/diab.30.9.735. [DOI] [PubMed] [Google Scholar]
- Schauder P., McIntosh C., Panten U., Arends J., Arnold R., Frerichs H., Creutzfeldt W. Dynamics of somatostatin and insulin release from isolated rat pancreatic islets: evidence for intraislet interactions between B cells and D cells. Metabolism. 1978 Sep;27(9 Suppl 1):1211–1214. doi: 10.1016/0026-0495(78)90044-6. [DOI] [PubMed] [Google Scholar]
- Schusdziarra V., Harris V., Conlon J. M., Arimura A., Unger R. Pancreatic and gastric somatostatin release in response to intragastric and intraduodenal nutrients and HCl in the dog. J Clin Invest. 1978 Sep;62(3):509–518. doi: 10.1172/JCI109154. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schusdziarra V., Rouiller D., Harris V., Conlon J. M., Unger R. H. The response of plasma somatostatin-like immunoreactivity to nutrients in normal and alloxan diabetic dogs. Endocrinology. 1978 Dec;103(6):2264–2273. doi: 10.1210/endo-103-6-2264. [DOI] [PubMed] [Google Scholar]
- Schusdziarra V., Zyznar E., Rouiller D., Harris V., Unger R. H. Free somatostatin in the circulation: amounts and molecular sizes of somatostatin-like immunoreactivity in portal, aortic, and vena caval plasma of fasting and meal-stimulated dogs. Endocrinology. 1980 Nov;107(5):1572–1576. doi: 10.1210/endo-107-5-1572. [DOI] [PubMed] [Google Scholar]
- Unger R. H., Aguilar-Parada E., Müller W. A., Eisentraut A. M. Studies of pancreatic alpha cell function in normal and diabetic subjects. J Clin Invest. 1970 Apr;49(4):837–848. doi: 10.1172/JCI106297. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Unger R. H., Orci L. Glucagon and the A cell: physiology and pathophysiology (first two parts). N Engl J Med. 1981 Jun 18;304(25):1518–1524. doi: 10.1056/NEJM198106183042504. [DOI] [PubMed] [Google Scholar]
- YALOW R. S., BERSON S. A. Immunoassay of endogenous plasma insulin in man. J Clin Invest. 1960 Jul;39:1157–1175. doi: 10.1172/JCI104130. [DOI] [PMC free article] [PubMed] [Google Scholar]